Hemochromatosis epidemiology and demographics
Jump to navigation Jump to search
Hemochromatosis epidemiology and demographics On the Web
American Roentgen Ray Society Images of Hemochromatosis epidemiology and demographics
Risk calculators and risk factors for Hemochromatosis epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. ; Associate Editor(s)-in-Chief: Sunny Kumar MD 
Prevalence of hemochromatosis is 6 times higher in white persons than in black persons.It is often described as a "Celtic mutation"--originating in a Celtic population in central Europe and spreading west and north by population movement.
Epidemiology and Demographics
Hemochromatosis is one of the most common inheritable genetic defects.
- In 2016, the incidence of C282Y is estimated to be 5400 cases per 100,000.
- In 2016, the incidence of H63D is estimated to be 13500 cases per 100,000.
- In 2017, the prevalence of Hemochromatosis was estimated to be from 500 case in 100000 individuals.
- The carrier state is estimated to be approximately 10000 in 100000.
- Prevalence of hemochromatosis is 6 times higher in white persons than in black persons.
- C282Y homozygotes account for 82-90% of clinical diagnoses of hereditary hemochromatosis among persons of northern European descent
- Irish have highest prevalence of hemochromatosis.
- In 2005, estimated prevalence of C282Y homozygotes was higher in non-Hispanic whites than in Native Americans.
- Non-Hispanic whites 44000 cases in 100000.
- Native Americans 11000 cases in 100000.
- Hispanics 270 cases in 100000
- Blacks 140 cases in 100000
- Pacific Islanders cases 120 in 100000
- Asians less then 1 case in 100000
- It is often described as a "Celtic mutation"--originating in a Celtic population in central Europe and spreading west and north by population movement.
- The European countries with the highest prevalence include Ireland, France, and Denmark.
- ↑ Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997). "Global prevalence of putative haemochromatosis mutations". J Med Genet. 34 (4): 275–8. PMC 1050911. PMID 9138148.
- ↑ Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD; et al. (2005). "Hemochromatosis and iron-overload screening in a racially diverse population". N Engl J Med. 352 (17): 1769–78. doi:10.1056/NEJMoa041534. PMID 15858186.